SpaceX Scrubs Starship Test Flight Plans Friday Attempt as V3 Debut Approaches Borosil Glass Works Surges Over 200 in One Year Whats Driving the Momentum White House Highlights Soybean and Rare Earth Deals From TrumpXi Summit China Emphasizes Tariff Cut Possibilities Dropbox Founder Drew Houston Steps Down as CEO After 19 Years Transitions to Executive Chairman GameSquare Holdings Receives Amended Schedule 13D Filing Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines Nucor Q1 2026 Earnings Steelmaker Beats Profit Expectations as Shares Advance CTAS Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Unavailable Mesabi Trust MSB Q1 2026 Earnings EPS of 021 Highlights Ongoing Iron Ore Headwinds GTES Q1 2026 Earnings EPS Beat with 47 Surprise Amid Steady Demand BioHarvest Sciences Q1 2025 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress American Coastal Insurance Corporation Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines OXSQG Holds Steady at 2435 as FixedIncome Investors Eye Rate Environment Infinity Natural Resources INR Holds Steady Near Support Targets Resistance Breakout Generation Essentials Group TGE Holds Support Eyes Resistance at 111 Flexsteel Industries FLXS Nears Support After Modest Pullback DTW Inches Higher Amid FixedIncome Stability Debenture Holds Steady at 2116 South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions Seer Inc Q1 2026 Earnings Narrower Loss Per Share Leads to Modest Stock Gain EDAP TMS Holds Steady Near Support After Modest Gain Avanos Medical AVNS Holds Steady Near Key Support Treading Water or Poised for a Move iQSTEL Inc IQST Falls 331 as Shares Test Key Support Levels DRTSW Plunges 14 as Selling Pressure Intensifies Key Support Levels in Focus Nuveen Municipal Credit Income Fund NZF Holds Steady Near Resistance as Income Seekers Eye Yield Espey Mfg Electronics Corp ESP Edges Higher Amid Consolidation Near Key Resistance Occidental Petroleum OXY Gains Modestly as Support Holds Above Key Level Beam Therapeutics BEAM Edges Higher as Investors Weigh Gene Editing Sector Outlook